Federal motion is crucial to curb PBMs’ anti-competitive practices also to involve accountability for that marketplace. EmployersRx and allies urge Congress to carry on its momentum to do away with PBM business practices driving up the cost of drugs for American companies and employees. Now is the opportunity for PBMs https://pauly281ogw8.bloggactif.com/profile